关闭 您好,检测到您使用的是Internet Explorer 6,建议升级浏览器以达视觉到最佳效果及最佳浏览速度。 Google ChormeFirefoxInternet Explorer 8
      

Healthplex Expo 2018
Natural & Nutraceutical Products China 2018

20-22 June, 2018 SNIEC, Shanghai, China

Nutraceutical Industry Development Conference

Home > Events > Nutraceutical Industry Development Conference

The 4th Nutraceutical Industry Development Conference

- China's Market Entry Strategy for Foreign Dietary Supplements

Date: 13:30-17:00  20 June 2017

          9:30-12:30    21 June 2017

Location: Meeting Room E6-M36, SNIEC, Shanghai, China


In 2017, the nutrition and health industry faced the toughest regulation ever on the R&D, production, sales and use of nutritional and health products. Multi-pronged regulatory policies posed a huge challenge to the industry. With the promulgation and implementation of the "Healthy China" strategy and the Outline of Healthy China Plan 2030, the front of disease prevention and treatment has been advanced constantly and the focus has been shifted from treatment to prevention, creating an unprecedented opportunity for the development of the nutrition and health industry.

To keep domestic and foreign enterprises updated on the latest polices and technologies, and help enterprises develop the domestic and international markets and seek partners, during Healthplex Expo 2017 and Natural & Nutraceutical Products China 2017 (HNC2017) in Shanghai, the China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) and UBM Sinoexpo will continue to organize Nutraceutical Industry Development Conference. Nearly 100 executives and market researchers from the industry attended the conference last year, and most of them said that the industrial experts' detailed explanation of policies and accurate analysis of the market will be effective to import foreign products into China.

Themed "China Market Entry Strategy for Foreign Dietary Supplements" again, the conference will invite heads of state ministries and commissions such as the Ministry of Commerce (MOFCOM), the General Administration of Quality Supervision, Inspection and Quarantine (AQSIQ) Ministry of Commerce of the People’s Republic of China and the China Food and Drug Administration (CFDA), health food review experts, as well as renowned entrepreneurs, to discuss issues such as China's latest nutrition and health policies, the technical requirements of health food registration and filing, cross-border e-commerce, market trends and brand building.

Conference Agenda

Module A: Policy Regulations & Technical Requirements 

13:30-17:00 June 20, 2017

Moderator: Zhang Zhongpeng, Secretary-General of the Dietary Supplement Committee 

No. 

Topic 

Speaker 

1

Welcome speech

China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE)

2

Interpretation of the Regulations on the Implementation of Food Safety Law and relevant regulations on health food

China Food and Drug Administration (CFDA)

3

Chinese policies for cross-border e-commerce and the progress of cross-border e-commerce comprehensive pilot areas

Ministry of Commerce of the People’s Republic of China (MOFCOM)

4

Construction of the traceability system of imported nutrition and health food

Li Li, Chinese Academy of Inspection and Quarantine

5

Technical requirements of imported health food registration or filing

Zhang Baoxian, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences

6

Analysis of essentials of imported health food declaration

Li Guiying, CCCMHPIE

Module B: Market Focuses & Brand Promotion 

09:30-12:00 June 21, 2017

Moderator: Li Guiying, Deputy Secretary-General of the Dietary Supplement Committee 

No. 

Topic 

Speaker 

1

Situation analysis and regulatory requirements of nutrition and health food import and export

Zhang Zhongpeng, Secretary-General of CCCMHPIE

2

Development of precision nutrition and trend of product R&D

Zhang Xuguang, By-Health Co., Ltd.

3

Setting and significance of industrial standards for food with special formulations

Liu Jie, U.S. Pharmacopeial Convention

4

Australian natural health product regulations and market focuses ----“Australia: 2020  The future of Regulation”

Dusko Pejnovic, President of Complementary Medicines Australia (CMA)

5

Cross-border e-commerce development and hot brands

JD Group

6

How to promote nutrition and health food brands in China

ATRIUM Group

 *In case of any change to the agenda, the actual agenda shall prevail; the organizer reserves the right to interpret the conference.

 

Speaker 


Vice President , China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE)
Dr. Xu Ming
Dr.Xu Ming is the vice president of China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE).He is a key industry’s opinion leader with an educational background of industrial economics, has been participating a lot in formulating the policies and regulations in China's healthcare industry, such as the promotion of international trade and investment, quality control of China-made medicinal products, enhancing the R&D capabilities and upgrading of the industrial structure, etc. He is one of the writers of the 12 th &13th Five-Year Plan of China's Healthcare Industry and the head of the taskforce to draft the 12 th Five-Year Plan of China's Import and Export of Pharmaceuticals and Medical Devices and Equipment. He is a member of evaluation committee for the National Industrial Development Bases and the head of the evaluation committee for the National Foreign Trade Bases for the Healthcare Industry. He has been invited to be the leader of the expert groups to review and evaluate many national projects in the healthcare sector by different ministries of the Chinese government, such as MOFCOM, NDRC, NHFPC, MIIT, AQSIQ,CFDA. He has worked very closely on many initiatives with FDA, EMA, EDQM and other food and drug administrations, associations, NGOs, academic institutions in various fields.

Deputy Director, China National Center for Food Safety HACCP Application Research Center CAIQ)
Li Li
Engaged in the study of HACCP and food safety detection techniques. Host to participate in more than 10 national, provincial and Shandong bureau’s scientific research subject. Established 4 national standards and 6 SN standards as the first completed person. Published more than 20 papers and be involved in many monographs program. Awarded the first prize three times, third prize twice for ‘Technological Inspection’ of General Administration of Quality Supervision, Inspection and Quarantine. Awarded first prize twice of Chinese the Chinese association of science and technology analysis test (CAIA), Innovation prize of national instrument institute for twice. 

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
Zhang Baoxian

Researcher and Doctor’s Tutor at Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences; Vice Director Member of Preparation Committee, Chinese Pharmacopoeia Commission; Pharmacy Review Expert and Health Food Review Expert at China Food & Drug Administration.

Researcher and Doctor’s Tutor; member of Preparation Committee, Chinese Pharmacopoeia Commission; Director of Chinese Medicine Committee, World Federation of Chinese Medicine Societies; Executive Director of New Chinese Drug Delivery System Committee, World Federation of Chinese Medicine Societies; Pharmacy Review Expert and Health Food Review Expert at China Food & Drug Administration; Expert in Expert Service Team, Ministry of Human Resources and Social Security; Review Expert for Sponsored Research Programs of Returned Chinese Studying Overseas, Ministry of Human Resources and Social Security; Review Expert at Beijing Food & Drug Administration; Technical Counselling Expert for Heilongjiang Province; and Editor of Chinese Journal of Experimental Traditional Medical Formulae.

Baoxian Zhang has spearheaded one research in 863 Program of China (national program for high-tech researches); two researches of State Administration of Traditional Chinese Medicine; has participated in one research in National Natural Science Foundation as the Vice head of Research Team or academic pillar, and one research in the 8th Five-year Plan, 9th Five-year Plan, 10th Five-year Plan and 11th Five-year Plan respectively; and one research of the New Medicine Foundation in the Ministry of Science and Technology of China; Baoxian Zhang has received 12 new-medicine certificates, 3 clinic experiment approvals, and 8 invention patents; he has published 26 academic theses, and three books. His research orientation: study of new targeted drug delivery system of Chinese medicine.

Project Director of China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE)
Li Guiying

Graduated from the Institute of Medicinal Plant Development, Peking Union Medical College, Tsinghua University, LI is the Pubic Nutritionist, whose research orientation is the policy regulation, laws and regulations in the field of medicine and health care. LI has participated in many research projects in the Ministry of Commerce. She once worked in the Health Food Office in National Engineering Centre for Development of New Chinese Compound Medicines. For many times, she has provided consultancy service for medicine registration of TONG REN TANG and SINOPHARM. Till today, she has provided consultancy and specific registration service for hundreds of health food, medical devices and cosmetics from USA, Japan, Korea, UK and Australia for their access to market in China.



 Director, CCCMHPIE
Zhang Zhongpeng

Mr. Zhang graduated from China Pharmaceutical University with a Master of Chinese Medicine. He is the deputy director of the China Chamber of Commerce for Import and Export of Medicines & Health Products (CCCMHPIE), the deputy director of Technical Service Center of CCCMHPIE, the general secretary of HEALTHPLEX, the deputy director of the Office of Standard Certification of the Foreign Trade of the Green Trade, and a member of the editorial committee of China Contemporary Chinese Medicine.

He is devoted to coordinating and promoting the international trade of medicine and health products and analyzing the trade statistics of the market home and abroad. He specializes on the policy and the market trend of the health product industry home and abroad. He is responsible for the international cooperation, projects connection, strategic development and brand support of those outstanding dietary supplement companies. 

irector of Nutrition and Health Research Centre, By-Health Co., Ltd.
Zhang Xuguang
Dr Xuguang (Felix) Zhang had his PhD in Human Nutrition (Medicine) in the Rowett Institute of Nutrition & Health, Scotland, UK. Before he joined in By-Heath (China), he had worked for over 9 years on medical/functional food development for FRDC Fonterra (NZ), University of Aberdeen (UK), Science in Sport Plc (UK), and Provexis Plc (UK). Dr Zhang had also led scientific research projects in CVDs and metabolic health when he worked as a Research Fellow in Rowett Institute. In Provexis Plc, working as a Senior Research Scientist, Dr Zhang and his team delivered their core functional ingredient FruitFlow, which won the first new health claim in Europe under the Article 13.5 EFSA. Dr Zhang is a Registered Nutritionist (Nutrition Science) in the UK. Now he is working as Director of Science and Technology Centre, Director of Nutrition and Health Research Centre in By-Health Co. Ltd China.

Sr. Strategic Customer Development Manager, U.S. Pharmacopeial Convention
Liu Jie

Jie Liu is the Sr. Strategic Customer Development Manager, Food and Dietary Supplement & Herbal Medicines, joined USP in 2008. In his current role, Jie works closely with various USP divisions to support the effort to acquire monographs and reference materials for chemical drugs, food ingredients, and dietary supplements from key constituencies. In responding to the challenges and risks of food fraud, Jie is taking the responsibility to introduce USP Food Fraud Mitigation tools and guidance to stakeholders to help design and implement food fraud risk mitigation plan. Jie has over 15 years of experience of standards setting in pharmaceutical, food and dietary supplements, he participated in drafting over 162 USP standards, including 96 food and dietary supplements and herbal medicine standards.


President – Complementary Medicines Australia
Dusko Pejnovic

Mr Pejnovic is the President of the CMA Board and is the CEO of Lipa Pharmaceuticals Ltd. With over thirty years of extensive experience across complementary, pharmaceutical, food, FMCG and B2B services, Dusko has held senior executive roles encompassing business development, sales and marketing, production, technical services and quality functions. A Fellow of the Australian Institute of Management, and holding MBA and BSc qualifications, Dusko has a background of successful engagement with a broad range of government and Industry stakeholders across healthcare, regulatory and commercial sectors.

Complementary Medicines Australia (CMA) is the peak industry body for the complementary medicines industry, representing members across the supply chain, including manufacturers, importers, exporters, raw material suppliers, wholesalers, distributors and retailers. CMA promotes appropriate industry regulation and advancement to ensure consumers have access to complementary medicines of the highest quality.

Lipa Pharmaceuticals Ltd is Australia’s leading, full service, integrated contract manufacturer of dietary supplements and OTC pharmaceutical products. Lipa’s core manufacturing competencies include tablets, soft gelatine capsules, two piece hard gelatine capsules, powders, liquids and creams. Lipa’s success and reputation has been built on providing customers with outstanding customer services, quality and value.

Managing Director of Asia Pacific & Greater China, Atrium Innovations
Jason Zhang

Jason Zhang is currently Managing Director of Asia Pacific & Greater China for Atrium Innovations, an innovative leader in science-based nutritional health products, with core brands, including Garden of Life, Wobenzym & Pure Encapsulations. Jason is responsible for helping establish Atrium Innovations as a leading supplement business in Asia Pacific.

Jason has over 20 years of diverse business experience with tremendous expertise in China.  Most recently, Jason was the Country Manager for Blackmores in China, Australia’s leading ASX listed natural healthcare company. Previous to Blackmores, Jason also had abundant experience working with a number of leading multi-national companies cross different industries, including Lion Nathan, Nike, Mars and Kantar Retail.

Jason has a Law degree from Suzhou University in China and an MBA from Leeds University in the UK.

 


Register now to enjoy an early bird price. Exhibitors can have more discounts.


Contact:


Ms. Nico Shen

Tel: +86-21-33392289

Email: nico.shen@ubmsinoexpo.com

Ms. Monika Xing

Tel:+86-10-58036297

Email: xingcheng@cccmhpie.org.cn

 

Why Attend?

- Important guest speakers: We will invite government officials, industrial experts and representatives of industrial leading enterprises to attend the conference.

- Authoritative interpretation of market regulations: Interpreting the latest health food regulations, as well as the requirements of imported health food registration and filing.

- Real-time sharing of industry focuses: Sharing the latest trends of cross-border e-commerce and the experience of foreign health food enterprises in brand building.

- Concurrence with health food exhibition - HNC: On the sidelines of the conference, attendees can visit Asia's largest nutraceutical exhibition and meet the best colleagues in the health food industry.

  


×

Follow us

Scan the QR code Follow HNC
×

Email Subscription

×

Search HNC 2017